BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 18663084)

  • 21. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
    Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
    Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
    Ky B; Burke A; Tsimikas S; Wolfe ML; Tadesse MG; Szapary PO; Witztum JL; FitzGerald GA; Rader DJ
    J Am Coll Cardiol; 2008 Apr; 51(17):1653-62. PubMed ID: 18436117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) accelerates atherosclerosis in uremic mice.
    Pedersen TX; McCormick SP; Tsimikas S; Bro S; Nielsen LB
    J Lipid Res; 2010 Oct; 51(10):2967-75. PubMed ID: 20584868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner.
    Assini JM; Clark JR; Youssef A; Xing C; Doerfler AM; Park SH; Saxena L; Yaseen AB; Børen J; Gros R; Bao G; Lagor WR; Boffa MB; Koschinsky ML
    Atherosclerosis; 2023 Nov; 384():117150. PubMed ID: 37290980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly of lipoprotein (a) in transgenic rabbits expressing human apolipoprotein (a).
    Fan J; Araki M; Wu L; Challah M; Shimoyamada H; Lawn RM; Kakuta H; Shikama H; Watanabe T
    Biochem Biophys Res Commun; 1999 Feb; 255(3):639-44. PubMed ID: 10049763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
    Gilliland TC; Liu Y; Mohebi R; Miksenas H; Haidermota S; Wong M; Hu X; Cristino JR; Browne A; Plutzky J; Tsimikas S; Januzzi JL; Natarajan P
    J Am Coll Cardiol; 2023 May; 81(18):1780-1792. PubMed ID: 37137588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.
    Bergmark C; Dewan A; Orsoni A; Merki E; Miller ER; Shin MJ; Binder CJ; Hörkkö S; Krauss RM; Chapman MJ; Witztum JL; Tsimikas S
    J Lipid Res; 2008 Oct; 49(10):2230-9. PubMed ID: 18594118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein(a) catabolism: a case of multiple receptors.
    McCormick SPA; Schneider WJ
    Pathology; 2019 Feb; 51(2):155-164. PubMed ID: 30595508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
    Fredrikson GN; Björkbacka H; Söderberg I; Ljungcrantz I; Nilsson J
    J Intern Med; 2008 Dec; 264(6):563-70. PubMed ID: 18783480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
    Jenner JL; Seman LJ; Millar JS; Lamon-Fava S; Welty FK; Dolnikowski GG; Marcovina SM; Lichtenstein AH; Barrett PH; deLuca C; Schaefer EJ
    Metabolism; 2005 Mar; 54(3):361-9. PubMed ID: 15736114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100.
    Yu RZ; Lemonidis KM; Graham MJ; Matson JE; Crooke RM; Tribble DL; Wedel MK; Levin AA; Geary RS
    Biochem Pharmacol; 2009 Mar; 77(5):910-9. PubMed ID: 19056355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
    Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.
    Kastelein JJ; Wedel MK; Baker BF; Su J; Bradley JD; Yu RZ; Chuang E; Graham MJ; Crooke RM
    Circulation; 2006 Oct; 114(16):1729-35. PubMed ID: 17030687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB.
    van der Hoek YY; Lingenhel A; Kraft HG; Defesche JC; Kastelein JJ; Utermann G
    J Clin Invest; 1997 May; 99(9):2269-73. PubMed ID: 9151801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
    Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
    JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mipomersen.
    Am J Cardiovasc Drugs; 2010; 10(4):271-9. PubMed ID: 20653334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice.
    Teivainen PA; Eliassen KA; Rubin EM; Djurovic S; Berg K
    Lipids Health Dis; 2004 May; 3():8. PubMed ID: 15134578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.
    Schneider M; Witztum JL; Young SG; Ludwig EH; Miller ER; Tsimikas S; Curtiss LK; Marcovina SM; Taylor JM; Lawn RM; Innerarity TL; Pitas RE
    J Lipid Res; 2005 Apr; 46(4):769-78. PubMed ID: 15654123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of mipomersen in the management of familial hypercholesterolaemia.
    Gelsinger C; Steinhagen-Thiessen E; Kassner U
    Drugs; 2012 Jul; 72(11):1445-55. PubMed ID: 22799743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
    Clarke R; Hammami I; Sherliker P; Valdes-Marquez E; Watkins H; Hill M; Yang X; Tsimikas S; Hopewell JC;
    Atherosclerosis; 2022 Aug; 354():15-22. PubMed ID: 35803063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.